zirconium has been researched along with Cancer of Head in 12 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 5 (41.67) | 29.6817 |
| 2010's | 5 (41.67) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Azevedo, EC; Baik, FM; Castillo, J; Chin, FT; Colevas, AD; Duan, H; Ferri, V; Freeman, L; Hom, M; Iagaru, A; Kaplan, MJ; Koran, ME; Lee, YJ; Martin, BA; Raymundo, RC; Rosenthal, EL; Shen, B; Valencia, A; van den Berg, NS; Zhou, Q | 1 |
| Bahce, I; de Gruijl, TD; Elgadi, M; Grempler, R; Hesse, R; Huisman, MC; Menke-van der Houven van Oordt, CW; Miedema, IHC; Peltzer, A; Pitarch, AP; Thiele, A; van Dongen, GAMS; Vugts, DJ; Zwezerijnen, GJC | 1 |
| Hansen, AE; Hasenberg, M; Jensen, AI; Jørgensen, JT; Kjær, A; Maurer, A; Pichler, B; Rolle, AM; Severin, GW; Wiehr, S | 1 |
| Bartelink, H; Even, AJ; Hamming-Vrieze, O; Heukelom, J; Hoeben, A; Hoebers, F; Lambin, P; Mottaghy, FM; Tesselaar, ME; van Dongen, GA; van Elmpt, W; Vogel, WV; Vugts, DJ; Winnepenninckx, VJ; Zegers, CM | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; de Bree, R; Jauw, YW; Leemans, CR; Roos, JC; van Dongen, GA | 1 |
| Budde, M; Jurek, P; Kiefer, GE; Perk, LR; van Dongen, GA; Visser, GW; Vosjan, MJ | 1 |
| Boerman, OC; Bussink, J; Franssen, GM; Hoeben, BA; Kaanders, JH; Oosterwijk, E; Oyen, WJ; Rijken, PF; Troost, EG; van Dongen, GA | 1 |
| Baclayon, M; de Bree, R; Heuveling, DA; Hoekstra, OS; Leemans, CR; Roos, WH; van Dongen, GA; Visser, GW; Wuite, GJ | 1 |
| Boellaard, R; Boerman, OC; Finn, R; Snow, GB; Stigter-van Walsum, M; van Dongen, GA; van Eerd, JE; Verel, I; Visser, GW; Vosjan, MJ | 1 |
| Boellaard, R; Boerman, OC; Lammertsma, AA; Snow, GB; van Dongen, GA; van Eerd, J; Verel, I; Visser, GW | 1 |
| Zalutsky, MR | 1 |
| Boellaard, R; Börjesson, PK; Castelijns, JA; Comans, EF; de Bree, R; Jauw, YW; Kummer, JA; Lammertsma, AA; Leemans, CR; Roos, JC; van Dongen, GA; Vosjan, MJ | 1 |
2 trial(s) available for zirconium and Cancer of Head
| Article | Year |
|---|---|
89Zr-panitumumab Combined With 18F-FDG PET Improves Detection and Staging of Head and Neck Squamous Cell Carcinoma.
Topics: Adult; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Panitumumab; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Sensitivity and Specificity; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2022 |
Radiation dosimetry of 89Zr-labeled chimeric monoclonal antibody U36 as used for immuno-PET in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Bone Marrow; Carcinoma, Squamous Cell; Clinical Trials as Topic; Drug-Related Side Effects and Adverse Reactions; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Male; Middle Aged; Positron-Emission Tomography; Radiation Dosage; Radioisotopes; Radiometry; Recombinant Fusion Proteins; Tissue Distribution; Zirconium | 2009 |
10 other study(ies) available for zirconium and Cancer of Head
| Article | Year |
|---|---|
Topics: Carcinoma, Non-Small-Cell Lung; Cell Line, Tumor; Head and Neck Neoplasms; Humans; Lung Neoplasms; Positron-Emission Tomography; Radioisotopes; Squamous Cell Carcinoma of Head and Neck; Zirconium | 2023 |
The impact of weakly bound ⁸⁹Zr on preclinical studies: non-specific accumulation in solid tumors and aspergillus infection.
Topics: Animals; Aspergillosis; Aspergillus fumigatus; Cell Line, Tumor; Colorectal Neoplasms; Female; Head and Neck Neoplasms; Humans; Hydrolysis; Ligands; Lung; Mice; Oxalic Acid; Pentetic Acid; Positron-Emission Tomography; Radioisotopes; Tissue Distribution; Water; Zirconium | 2015 |
Quantitative assessment of Zirconium-89 labeled cetuximab using PET/CT imaging in patients with advanced head and neck cancer: a theragnostic approach.
Topics: Aged; Antineoplastic Agents, Immunological; Cetuximab; ErbB Receptors; Female; Head and Neck Neoplasms; Humans; Male; Middle Aged; Molecular Imaging; Neoplasm Staging; Positron Emission Tomography Computed Tomography; Radioisotopes; Treatment Outcome; Zirconium | 2017 |
Conjugation and radiolabeling of monoclonal antibodies with zirconium-89 for PET imaging using the bifunctional chelate p-isothiocyanatobenzyl-desferrioxamine.
Topics: Animals; Antibodies, Monoclonal; Chelating Agents; Deferoxamine; Head and Neck Neoplasms; Humans; Isothiocyanates; Mice; Mice, Nude; Positron-Emission Tomography; Radioisotopes; Radiopharmaceuticals; Transplantation, Heterologous; Zirconium | 2010 |
PET of hypoxia with 89Zr-labeled cG250-F(ab')2 in head and neck tumors.
Topics: Animals; Antibodies, Monoclonal; Autoradiography; Carbonic Anhydrase Inhibitors; Head and Neck Neoplasms; Hypoxia; Image Processing, Computer-Assisted; Immunoglobulin Fab Fragments; Immunoglobulin G; Immunohistochemistry; Isotope Labeling; Mice; Mice, Inbred BALB C; Nitroimidazoles; Organometallic Compounds; Positron-Emission Tomography; Quality Control; Radiation-Sensitizing Agents; Radiopharmaceuticals; Tissue Distribution; Xenograft Model Antitumor Assays; Zirconium | 2010 |
89Zr-nanocolloidal albumin-based PET/CT lymphoscintigraphy for sentinel node detection in head and neck cancer: preclinical results.
Topics: Albumins; Animals; Carcinoma, Squamous Cell; Cell Line, Tumor; Disease Models, Animal; Female; Head and Neck Neoplasms; Lymphatic Metastasis; Particle Size; Positron-Emission Tomography; Rabbits; Radioisotopes; Radiopharmaceuticals; Technetium Tc 99m Aggregated Albumin; Tomography, X-Ray Computed; Zirconium | 2011 |
Long-lived positron emitters zirconium-89 and iodine-124 for scouting of therapeutic radioimmunoconjugates with PET.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Glycoproteins; Head and Neck Neoplasms; Humans; Hyaluronan Receptors; Immunoconjugates; Iodine Radioisotopes; Isotope Labeling; Mice; Mice, Nude; Radioisotopes; Recombinant Fusion Proteins; Rhenium; Time Factors; Tissue Distribution; Tomography, Emission-Computed; Xenograft Model Antitumor Assays; Yttrium Radioisotopes; Zirconium | 2003 |
Quantitative 89Zr immuno-PET for in vivo scouting of 90Y-labeled monoclonal antibodies in xenograft-bearing nude mice.
Topics: Animals; Antibodies, Monoclonal; Carcinoma, Squamous Cell; Cell Line, Tumor; Female; Head and Neck Neoplasms; Humans; Isotope Labeling; Metabolic Clearance Rate; Mice; Mice, Nude; Neoplasm Transplantation; Organ Specificity; Phantoms, Imaging; Radioimmunotherapy; Radioisotopes; Radiopharmaceuticals; Statistics as Topic; Tissue Distribution; Tomography, Emission-Computed; Transplantation, Heterologous; Yttrium Radioisotopes; Zirconium | 2003 |
Potential of immuno-positron emission tomography for tumor imaging and immunotherapy planning.
Topics: Antibodies, Monoclonal; Carcinoma, Squamous Cell; Head and Neck Neoplasms; Humans; Neoplasm Staging; Positron-Emission Tomography; Radioimmunotherapy; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |
Performance of immuno-positron emission tomography with zirconium-89-labeled chimeric monoclonal antibody U36 in the detection of lymph node metastases in head and neck cancer patients.
Topics: Aged; Antibodies, Monoclonal; Carcinoma, Squamous Cell; False Positive Reactions; Female; Fluorodeoxyglucose F18; Head and Neck Neoplasms; Humans; Isotope Labeling; Lymphatic Metastasis; Male; Middle Aged; Neck Dissection; Positron-Emission Tomography; Radioisotopes; Sensitivity and Specificity; Zirconium | 2006 |